Mr. Thomas' presentation, "Allograft Cellular Products - First Mover Advantage" will focus on how LifeNet Health has applied its experience and institutional knowledge about safety and efficacy in the cell-based product market - the fastest-growing segment in the bone graft substitute market.
http://ift.tt/1fbAVKN
http://ift.tt/1fbAVKN
No comments:
Post a Comment